Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

FKBP (FK506 Binding Protein)

  • Paolo D’Arrigo
  • Martina Tufano
  • Anna Rea
  • Simona Romano
  • Maria Fiammetta Romano
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101769

Synonyms

Synonyms for each gene and encoded protein are listed in Table 1.
FKBP (FK506 Binding Protein), Table 1

FKBP classification with synonyms of gene and protein

GENE

PROTEIN

Name

Other names

Name

Other names

MW (kDa)

FKBP1B

OTK4; FKBP1L; PKBP1L; PPIase; FKBP12.6

FKBP1B

FKBP12.6; calstabin 2; rotamase

11,782

FKBP1A

FKBP1; PKC12; PKCI2; FKBP12; PPIASE

FKBP1A

FKBP12; FKBP1; FKBP12-Exip3; calstabin 1; PKC inhibitor 2; rotamase

11,951

FKBP2

PPIase; FKBP-13

FKBP2

FKBP13; FKBP15.6; proline isomerase; rotamase; rapamycin-binding protein

15,649

FKBP11

FKBP19

FKBP11

FKBP19; rotamase

22,18

FKBP14

EDSKMH; FKBP22; IPBP12

FKBP14

FKBP22; rotamase

24,172

FKBP3

FKBP-3; FKBP25; PPIase; FKBP-25

FKBP3

FKBP25; rapamycin-binding protein; rotamase; rapamycin-selective 25 kDa immunophilin

25,177

FKBP7

FKBP23; PPIase

FKBP7

FKBP23; FKBP30; rotamase

30,009

FKBP6

FKBP36

FKBP6

FKBP36; inactive PPIase FKBP6; rotamase

37,214

AIP

ARA9; XAP2; XAP-2; FKBP16; FKBP37; SMTPHN

AIP

FKBP37; XAP3; HBVX-associated...

This is a preview of subscription content, log in to check access.

References

  1. Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ, George DL. Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene. 1999;18(43):5954–8.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 2010;86:551–9.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Arakawa H, Nagase H, Hayashi N, Fujiwara T, Ogawa M, Shin S, et al. Molecular cloning and expression of a novel human gene that is highly homologous to human FK506-binding protein 12 kDa (hFKBP-12) and characterization of two alternatively spliced transcripts. Biochem Biophys Res Commun. 1994;200:836–43.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Aston KI, Krausz C, Laface I, Ruiz-Castane E, Carrell DT. Evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of European descent. Hum Reprod. 2010;25:1383–97.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y, et al. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science. 2007;318:977–80.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Banasavadi-Siddegowda YK, Mai J, Fan Y, Bhattacharya S, Giovannucci DR, Sanchez ER, et al. FKBP38 peptidylprolyl isomerase promotes the folding of cystic fibrosis transmembrane conductance regulator in the endoplasmic reticulum. J Biol Chem. 2011;286:43071–80.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Barnes AM, Cabral WA, Weis M, Makareeva E, Mertz EL, Leikin S, et al. Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat. 2012;33:1589–98.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, Bourgeois S. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol. 1995;15:4395–402.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Baumann M, Giunta C, Krabichler B, Ruschendorf F, Zoppi N, Colombi M, et al. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet. 2012;90:201–16.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013;34:239–77.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Bett JS, Kanuga N, Richet E, Schmidtke G, Groettrup M, Cheetham ME, et al. The inherited blindness protein AIPL1 regulates the ubiquitin-like FAT10 pathway. PLoS One 2012;7:e30866PubMedPubMedCentralCrossRefGoogle Scholar
  12. Bhuiyan ZA, Hamdan MA, Shamsi ET, Postma AV, Mannens MM, Wilde AA, et al. A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22. J Cardiovasc Electrophysiol. 2007;18:1060–6.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Brown CA, Schmidt C, Poulter M, Hummerich H, Klohn PC, Jat P, et al. vitro screen of prion disease susceptibility genes using the scrapie cell assay. Hum Mol Genet. 2014;23:5102–8.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Bublik DR, Scolz M, Triolo G, Monte M, Schneider C. Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment. J Biol Chem. 2010;285:5274–81.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Bush KT, Hendrickson BA, Nigam SK. Induction of the FK506-binding protein, FKBP13, under conditions which misfold proteins in the endoplasmic reticulum. Biochem J. 1994;303:705–8.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Cai W, Kramarova TV, Berg P, Korbonits M, Pongratz I. The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor alpha. PLoS One 2011;6:e25201PubMedPubMedCentralCrossRefGoogle Scholar
  17. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A. 1995;28:1784–8.CrossRefGoogle Scholar
  18. Chen HS, Perdew GH. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem. 1994;269:27554–8.PubMedPubMedCentralGoogle Scholar
  19. Chen Y, Sternberg P, Cai J. Characterization of a Bcl-XL-interacting protein FKBP8 and its splice variant in human RPE cells. Invest Ophthalmol Vis Sci. 2008;49:1721–7.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Chen Z, Li Z, Wei B, Yin W, Xu T, Kotlikoff MI, et al. FKBP12.6-knockout mice display hyperinsulinemia and resistance to high-fat diet-induced hyperglycemia. FASEB J Off Publ Fed Am Soc Exp Biol. 2010;24:357–63.Google Scholar
  21. Cheung J, Smith DF. Molecular chaperone interactions with steroid receptors: an update. Mol Endocrinol. 2000;14:939–46.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF. Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol. 2005;19:1654–66.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Cho A, Ko HW, Eggenschwiler JT. FKBP8 cell-autonomously controls neural tube patterning through a Gli2- and Kif3a-dependent mechanism. Dev Biol. 2008;321:27–39.PubMedPubMedCentralCrossRefGoogle Scholar
  24. Cioffi DL, Hubler TR, Scammell JG. Organization and function of the FKBP52 and FKBP51 genes. Curr Opin Pharmacol. 2011;11:308–13.PubMedPubMedCentralCrossRefGoogle Scholar
  25. Coss MC, Winterstein D, Sowder 2nd RC, Simek SL. Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65). J Biol Chem. 1995;270:29336–41.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Crackower MA, Kolas NK, Noguchi J, Sarao R, Kikuchi K, Kaneko H, et al. Essential role of Fkbp6 in male fertility and homologous chromosome pairing in meiosis. Science. 2003;300:1291–5.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Davis EC, Broekelmann TJ, Ozawa Y, Mecham RP. Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway. J Cell Biol. 1998;140:295–303.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buee L, Debyser Z, et al. Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation. J Biol Chem. 2011;286:26687–701.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Edlich F, Lucke C. From cell death to viral replication: the diverse functions of the membrane-associated FKBP38. Curr Opin Pharmacol. 2011;11:348–53.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Edlich F, Weiwad M, Erdmann F, Fanghanel J, Jarczowski F, Rahfeld JU, et al. Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin. EMBO J. 2005;24:2688–99.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Erdmann F, Jarczowski F, Weiwad M, Fischer G, Edlich F. Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells. FEBS Lett. 2007;581:5709–14.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Erlejman AG, De Leo SA, Mazaira GI, Molinari AM, Camisay MF, Fontana V, et al. NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity. J Biol Chem. 2014;289:26263–76.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Fischer G, Aumüller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev Physiol Biochem Pharmacol. 2003;148:105–50.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Fusco D, Vargiolu M, Vidone M, Mariani E, Pennisi LF, Bonora E, et al. The RET51/FKBP52 complex and its involvement in Parkinson disease. Hum Mol Genet. 2010;19:2804–16.PubMedPubMedCentralCrossRefGoogle Scholar
  35. Gopalakrishna KN, Boyd K, Yadav RP, Artemyev NO. Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the gamma-Subunit of Its Client. J Biol Chem. 2016;291:16282–91.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Gudavicius G, Dilworth D, Serpa JJ, Sessler N, Petrotchenko EV, Borchers CH, et al. The prolyl isomerase, FKBP25, interacts with RNA-engaged nucleolin and the pre-60S ribosomal subunit. RNA. 2014;20:1014–22.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Halatsch ME, Löw S, Hielscher T, Schmidt U, Unterberg A, Vougioukas VI. Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib. Anticancer Res. 2008;28:3725–8.PubMedPubMedCentralGoogle Scholar
  38. Hamman BD, Hendershot LM, Johnson AE. BiP maintains the permeability barrier of the ER membrane by sealing the lumenal end of the translocon pore before and early in translocation. Cell. 1998;92:747–58.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T. Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab. 2011;29:279–90.PubMedPubMedCentralCrossRefGoogle Scholar
  40. Harbour ME, Breusegem SY, Seaman MN. Recruitment of the endosomal WASH complex is mediated by the extended ‘tail’ of Fam21 binding to the retromer protein Vps35. Biochem J. 2012;442:209–20.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Harding MW, Galat A, Uehling DE, Shreiber SLA. receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989;341:758–60.PubMedPubMedCentralCrossRefGoogle Scholar
  42. Hausch FFKBP. their role in neuronal signaling. Biochim Biophys Acta. 2015;1850:2035–40.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Henriksen R, Sorensen FB, Orntoft TF, Birkenkamp-Demtroder K. Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2011;32:671–6.CrossRefGoogle Scholar
  44. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17:2205–32.PubMedPubMedCentralCrossRefGoogle Scholar
  45. Hung DT, Schreiber SL. cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. Biochem Biophys Res Commun. 1992;184:733–8.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Ishikawa Y, Vranka J, Wirz J, Nagata K, Bachinger HP. The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens. J Biol Chem. 2008;283:31584–90.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Jarczowski F, Fischer G, Edlich F. FKBP36 forms complexes with clathrin and Hsp72 in spermatocytes. Biochemistry. 2008;47:6946–52.PubMedPubMedCentralCrossRefGoogle Scholar
  48. Jarczowski F, Jahreis G, Erdmann F, Schierhorn A, Fischer G, Edlich F. FKBP36 is an inherent multifunctional glyceraldehyde-3-phosphate dehydrogenase inhibitor. J Biol Chem. 2009;284:766–73.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Jiang MT, Lokuta AJ, Farrell EF, Wolff MR, Haworth RA, Valdivia HH. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res. 2002;91:1015–22.PubMedPubMedCentralCrossRefGoogle Scholar
  50. Jiang W, Cazacu S, Xiang C, Zenklusen JC, Fine HA, Berens M, et al. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. Neoplasia. 2008;10:235–43.PubMedPubMedCentralCrossRefGoogle Scholar
  51. Jin YJ, Burakoff SJ. The 25-kDa FK506-binding protein is localized in the nucleus and associates with casein kinase II and nucleolin. Proc Natl Acad Sci U S A. 1993;90:7769–73.PubMedPubMedCentralCrossRefGoogle Scholar
  52. Jin YJ, Albers MW, Lane WS, Bierer BE, Schreiber SL, Burakoff SJ. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A. 1991;88:6677–81.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Jinwal UK, Koren 3rd J, Borysov SI, Schmid AB, Abisambra JF, Blair LJ, et al. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci Off J Soc Neurosci. 2010;30:591–9.CrossRefGoogle Scholar
  54. Kanaya K, Sohocki MM, Kamitani T. Abolished interaction of NUB1 with mutant AIPL1 involved in Leber congenital amaurosis. Biochem Biophys Res Commun. 2004;317:768–73.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Kasai H, Kawakami K, Yokoe H, Yoshimura K, Matsuda M, Yasumoto J, et al. Involvement of FKBP6 in hepatitis C virus replication. Sci Rep. 2015;5:16699.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Kashuba EV, Gradin K, Isaguliants M, Szekely L, Poellinger L, Klein G, et al. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem. 2006;281:1215–23.PubMedPubMedCentralCrossRefGoogle Scholar
  57. Kazlauskas A, Poellinger L, Pongratz I. Two distinct regions of the immunophilin-like protein XAP2 regulate dioxin receptor function and interaction with hsp90. J Biol Chem. 2002;277:11795–801.PubMedPubMedCentralCrossRefGoogle Scholar
  58. Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B, et al. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res. 2003;63:1865–70.PubMedPubMedCentralGoogle Scholar
  59. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110(2):163–75.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot. 1987;40:1249.PubMedPubMedCentralCrossRefGoogle Scholar
  61. Koenekoop RK. An overview of Leber congenital amaurosis: a model to understand human retinal development. Surv Ophthalmol. 2004;49:379–98.PubMedPubMedCentralCrossRefGoogle Scholar
  62. Komura E, Tonetti C, Penard-Lacronique V, Chagraoui H, Lacout C, Lecouedic JP, et al. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res. 2005;65:3281–9.PubMedPubMedCentralCrossRefGoogle Scholar
  63. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E. XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res. 1996;24:4741–50.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation. 2001;103:2822–7.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Lam E, Martin M, Wiederrecht G. Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs. Gene. 1995a;160:297–302.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Lam E, Martin MM, Timerman AP, Sabers C, Fleischer S, Lukas T, et al. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem. 1995b;270:26511–22.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Lees MJ, Peet DJ, Whitelaw ML. Defining the role for XAP2 in stabilization of the dioxin receptor. J Biol Chem. 2003;278:35878–88.PubMedPubMedCentralCrossRefGoogle Scholar
  68. Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation. 2004;109:3208–14.PubMedPubMedCentralCrossRefGoogle Scholar
  69. Li J, Zoldak G, Kriehuber T, Soroka J, Schmid FX, Richter K, et al. Unique proline-rich domain regulates the chaperone function of AIPL1. Biochemistry. 2013;52:2089–96.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Lin IY, Yen CH, Liao YJ, Lin SE, Ma HP, Chan YJ, et al. Identification of FKBP11 as a biomarker for hepatocellular carcinoma. Anticancer Res. 2013;33:2763–9.PubMedPubMedCentralGoogle Scholar
  71. Linnert M, Lin YJ, Manns A, Haupt K, Paschke AK, Fischer G, et al. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction. Biochemistry. 2013;52:2097–107.PubMedPubMedCentralCrossRefGoogle Scholar
  72. Liu X, Bulgakov OV, Wen XH, Woodruff ML, Pawlyk B, Yang J, et al. AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A. 2004;101:13903–8.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Lopez E, Berna-Erro A, Salido GM, Rosado JA, Redondo PC. FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells. Biochim Biophys Acta. 2013;1833:652–62.PubMedPubMedCentralCrossRefGoogle Scholar
  74. Lopez-Ilasaca M, Schiene C, Kullertz G, Tradler T, Fischer G, Wetzker R. Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. J Biol Chem. 1998;273:9430–4.PubMedPubMedCentralCrossRefGoogle Scholar
  75. Martinez NJ, Chang HM, Borrajo Jde R, Gregory RI. The co-chaperones Fkbp4/5 control Argonaute2 expression and facilitate RISC assembly. RNA. 2013;19:1583–93.PubMedPubMedCentralCrossRefGoogle Scholar
  76. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365–76.PubMedPubMedCentralCrossRefGoogle Scholar
  77. McKeen HD, McAlpine K, Valentine A, Quinn DJ, McClelland K, Byrne C, et al. A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology. 2008;149:5724–34.PubMedPubMedCentralCrossRefGoogle Scholar
  78. McKeen HD, Byrne C, Jithesh PV, Donley C, Valentine A, Yakkundi A, et al. FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res. 2010;70:1090–100.PubMedPubMedCentralCrossRefGoogle Scholar
  79. Meng X, Lu X, Morris CA, Keating MTA. novel human gene FKBP6 is deleted in Williams syndrome. Genomics. 1998;52:130–7.PubMedPubMedCentralCrossRefGoogle Scholar
  80. Miyata Y, Chambraud B, Radanyi C, Leclerc J, Lebeau MC, Renoir JM, et al. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52. Proc Natl Acad Sci U S A. 1997;94:14500–5.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Murphy LA, Ramirez EA, Trinh VT, Herman AM, Anderson VC, Brewster JL. Endoplasmic reticulum stress or mutation of an EF-hand Ca(2+)-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis. Cell Stress Chaperones. 2011;16:607–19.PubMedPubMedCentralCrossRefGoogle Scholar
  82. Nakajima O, Nakamura F, Yamashita N, Tomita Y, Suto F, Okada T, et al. FKBP133: a novel mouse FK506-binding protein homolog alters growth cone morphology. Biochem Biophys Res Commun. 2006;346:140–9.PubMedPubMedCentralCrossRefGoogle Scholar
  83. Nakamura T, Yabe D, Kanazawa N, Tashiro K, Sasayama S, Honjo T. Molecular cloning, characterization, and chromosomal localization of FKBP23, a novel FK506-binding protein with Ca2+−binding ability. Genomics. 1998;54:89–98.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Nakata A, Urano D, Fujii-Kuriyama Y, Mizuno N, Tago K, Itoh H. G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. EMBO Rep. 2009;10:622–8.PubMedPubMedCentralCrossRefGoogle Scholar
  85. Neye H, Verspohl EJ. The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q. BMC Pharmacol. 2004;4:19.PubMedPubMedCentralCrossRefGoogle Scholar
  86. Ni L, Yang CS, Gioeli D, Frierson H, Toft DO, Paschal BM. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Mol Cell Biol. 2010;30:1243–53.PubMedPubMedCentralCrossRefGoogle Scholar
  87. Noguchi N, Yoshikawa T, Ikeda T, Takahashi I, Shervani NJ, Uruno A, et al. FKBP12.6 disruption impairs glucose-induced insulin secretion. Biochem Biophys Res Commun. 2008;371:735–40.PubMedPubMedCentralCrossRefGoogle Scholar
  88. Ochocka AM, Kampanis P, Nicol S, Allende-Vega N, Cox M, Marcar L, et al. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. FEBS Lett. 2009;583:621–6.PubMedPubMedCentralCrossRefGoogle Scholar
  89. Okadome T, Oeda E, Saitoh M, Ichijo H, Moses HL, Miyazono K, et al. Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo. J Biol Chem. 1996;271:21687–90.PubMedPubMedCentralCrossRefGoogle Scholar
  90. Olesen SH, Christensen LL, Sorensen FB, Cabezon T, Laurberg S, Orntoft TF, et al. Human FK506 binding protein 65 is associated with colorectal cancer. Mol Cell Proteomics: MCP. 2005;4:534–44.PubMedPubMedCentralCrossRefGoogle Scholar
  91. Pan YF, Viklund IM, Tsai HH, Pettersson S, Maruyama IN. The ulcerative colitis marker protein WAFL interacts with accessory proteins in endocytosis. Int J Biol Sci. 2010;6:163–71.PubMedPubMedCentralCrossRefGoogle Scholar
  92. Patterson CE, Abrams WR, Wolter NE, Rosenbloom J, Davis EC. Developmental regulation and coordinate reexpression of FKBP65 with extracellular matrix proteins after lung injury suggest a specialized function for this endoplasmic reticulum immunophilin. Cell Stress Chaperones. 2005;10:285–95 ; 11071917.PubMedPubMedCentralCrossRefGoogle Scholar
  93. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell. 2009;16:259–66.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Periyasamy S, Warrier M, Tillekeratne MP, Shou W, Sanchez ER. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Endocrinology. 2007;148:4716–26.PubMedPubMedCentralCrossRefGoogle Scholar
  95. Raitila A, Lehtonen HJ, Arola J, Heliovaara E, Ahlsten M, Georgitsi M, et al. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression. Am J Pathol. 2010;177:1969–76.PubMedPubMedCentralCrossRefGoogle Scholar
  96. Ramamurthy V, Niemi GA, Reh TA, Hurley JB. Leber congenital amaurosis linked to AIPL1: a mouse model reveals destabilization of cGMP phosphodiesterase. Proc Natl Acad Sci U S A. 2004;101:13897–902.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. 2003;107:2459–66.PubMedPubMedCentralCrossRefGoogle Scholar
  98. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 2003;22:1158–67.PubMedPubMedCentralCrossRefGoogle Scholar
  99. Robson T, Joiner MC, Wilson GD, McCullough W, Price ME, Logan I, et al. A novel human stress response-related gene with a potential role in induced radioresistance. Radiat Res. 1999;152:451–61.PubMedPubMedCentralCrossRefGoogle Scholar
  100. Romano MF, Avellino R, Petrella A, Bisogni R, Romano S, Venuta S. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells. Eur J Cancer. 2004;40:2829–36.PubMedPubMedCentralCrossRefGoogle Scholar
  101. Romano S, Mallardo M, Chiurazzi F, Bisogni R, D’Angelillo A, Liuzzi R, et al. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells. Haematologica. 2008;93(7):1039–48.PubMedPubMedCentralCrossRefGoogle Scholar
  102. Romano S, D’Angelillo A, Pacelli R, Staibano S, De Luna E, Bisogni R, et al. Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ. 2010;17:145–57.PubMedPubMedCentralCrossRefGoogle Scholar
  103. Romano S, Staibano S, Greco A, Brunetti A, Nappo G, Ilardi G, et al. FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential. Cell Death Dis. 2013;4:e578.PubMedPubMedCentralCrossRefGoogle Scholar
  104. Romano S, D’Angelillo A, D’Arrigo P, Staibano S, Greco A, Brunetti A, et al. FKBP51 increases the tumour-promoter potential of TGF-beta. Clin Transl Med. 2014;3:1.PubMedPubMedCentralCrossRefGoogle Scholar
  105. Romano S, D’Angelillo A, Romano MF. Pleiotropic roles in cancer biology for multifaceted proteins FKBPs. Biochim Biophys Acta. 2015a;1850:2061–8.PubMedPubMedCentralCrossRefGoogle Scholar
  106. Romano S, D’Angelillo A, Staibano S, Simeone E, D’Arrigo P, Ascierto PA, et al. Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients. Pigment Cell Melanoma Res. 2015b;28:442–52.PubMedPubMedCentralCrossRefGoogle Scholar
  107. Romano S, Xiao Y, Nakaya M, D’Angelillo A, Chang M, Jin J, et al. FKBP51 employs both scaffold and isomerase functions to promote NF-kappaB activation in melanoma. Nucleic Acids Res. 2015c;43:6983–9.PubMedPubMedCentralCrossRefGoogle Scholar
  108. Ruer-Laventie J, Simoni L, Schickel JN, Soley A, Duval M, Knapp AM, et al. Overexpression of Fkbp11, a feature of lupus B cells, leads to B cell tolerance breakdown and initiates plasma cell differentiation. Immun Inflamm Dis. 2015;3:265–79.PubMedPubMedCentralCrossRefGoogle Scholar
  109. Rulten SL, Kinloch RA, Tateossian H, Robinson C, Gettins L, Kay JE. The human FK506-binding proteins: characterization of human FKBP19. Mamm Genome: Off J Int Mamm Genome Soc. 2006;17:322–31.CrossRefGoogle Scholar
  110. Saita S, Shirane M, Nakayama KI. Selective escape of proteins from the mitochondria during mitophagy. Nat Commun. 2013;4:1410.PubMedPubMedCentralCrossRefGoogle Scholar
  111. Sanchez ER, Faber LE, Henzel WJ, Pratt WB. The 56-59-kilodalton protein identified in untransformed steroid receptor complexes is a unique protein that exists in cytosol in a complex with both the 70- and 90-kilodalton heat shock proteins. Biochemistry. 1990;29:5145–52.PubMedPubMedCentralCrossRefGoogle Scholar
  112. Sanokawa-Akakura R, Dai H, Akakura S, Weinstein D, Fajardo JE, Lang SE, et al. A novel role for the immunophilin FKBP52 in copper transport. J Biol Chem. 2004;279:27845–8.PubMedPubMedCentralCrossRefGoogle Scholar
  113. Sanokawa-Akakura R, Cao W, Allan K, Patel K, Ganesh A, Heiman G, et al. Control of Alzheimer’s amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One 2010;5:e8626PubMedPubMedCentralCrossRefGoogle Scholar
  114. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22:159–68.PubMedPubMedCentralCrossRefGoogle Scholar
  115. Schimmack G, Eitelhuber AC, Vincendeau M, Demski K, Shinohara H, Kurosaki T, et al. AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-kappaB signaling upon T cell activation. Cell Commun Signal: CCS. 2014;12:49.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Schmidt MV, Paez-Pereda M, Holsboer F, Hausch F. The prospect of FKBP51 as a drug target. ChemMedChem. 2012;7:1351–9.PubMedPubMedCentralCrossRefGoogle Scholar
  117. Schulke JP, Wochnik GM, Lang-Rollin I, Gassen NC, Knapp RT, Berning B, et al. Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS One 2010;5(7):e11717PubMedPubMedCentralCrossRefGoogle Scholar
  118. Shadidy M, Caubit X, Olsen R, Seternes OM, Moens U, Krauss S. Biochemical analysis of mouse FKBP60, a novel member of the FKPB family. Biochim Biophys Acta. 1999;1446:295–307.PubMedPubMedCentralCrossRefGoogle Scholar
  119. Shikawa Y, Bachinger HP. A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. J Biol Chem. 2014;289:18189–201.CrossRefGoogle Scholar
  120. Shirane M, Nakayama KI. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol. 2003;5:28–37.PubMedPubMedCentralCrossRefGoogle Scholar
  121. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 1989;341:755–7.PubMedPubMedCentralCrossRefGoogle Scholar
  122. Sivils JC, Storer CL, Galigniana MD, Cox MB. Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52). Curr Opin Pharmacol. 2011;11:314–9.PubMedPubMedCentralCrossRefGoogle Scholar
  123. Smith DF, Baggenstoss BA, Marion TN, Rimerman RA. Two FKBP-related proteins are associated with progesterone receptor complexes. J Biol Chem. 1993;268:18365–71.PubMedPubMedCentralGoogle Scholar
  124. Sohocki MM, Bowne SJ, Sullivan LS, Blackshaw S, Cepko CL, Payne AM, et al. Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis. Nat Genet. 2000;24:79–83.PubMedPubMedCentralCrossRefGoogle Scholar
  125. Standaert RF, Galat A, Verdine GL, Schreiber SL. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature. 1990;346:671–4.PubMedPubMedCentralCrossRefGoogle Scholar
  126. Stocki P, Sawicki M, Mays CE, Hong SJ, Chapman DC, Westaway D, et al. Inhibition of the FKBP family of peptidyl prolyl isomerases induces abortive translocation and degradation of the cellular prion protein. Mol Biol Cell. 2016;27:757–67.PubMedPubMedCentralCrossRefGoogle Scholar
  127. Sugata H, Matsuo K, Nakagawa T, Takahashi M, Mukai H, Ono Y, et al. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Neurosci Lett. 2009;459:96–9.PubMedPubMedCentralCrossRefGoogle Scholar
  128. Sun Z, Dong J, Zhang S, Hu Z, Cheng K, Li K, et al. Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins. J Proteome Res. 2014;13:1593–601.PubMedPubMedCentralCrossRefGoogle Scholar
  129. Sunnotel O, Hiripi L, Lagan K, McDaid JR, De Leon JM, Miyagawa Y, et al. Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study. Reprod Biol Endocrinol: RB&E. 2010;8:22.CrossRefGoogle Scholar
  130. Timerman AP, Ogunbumni E, Freund E, Wiederrecht G, Marks AR, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem. 1993;268:22992–9.PubMedPubMedCentralGoogle Scholar
  131. Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, et al. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A. 2005;102:14326–31.PubMedPubMedCentralCrossRefGoogle Scholar
  132. Trivellin G, Korbonits M. AIP and its interacting partners. J Endocrinol. 2011;210:137–55.PubMedPubMedCentralCrossRefGoogle Scholar
  133. Valentine A, O’Rourke M, Yakkundi A, Worthington J, Hookham M, Bicknell R, et al. FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. Clin Cancer Res: Off J Am Assoc Cancer Res. 2011;17:1044–56.CrossRefGoogle Scholar
  134. van der Spuy J. Focus on molecules: the aryl hydrocarbon receptor interacting protein-like 1 (AIPL1). Exp Eye Res. 2006;83:1307–8.PubMedPubMedCentralCrossRefGoogle Scholar
  135. Walensky LD, Gascard P, Fields ME, Blackshaw S, Conboy JG, Mohandas N, et al. The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J Cell Biol. 1998;141:143–53.PubMedPubMedCentralCrossRefGoogle Scholar
  136. Wang J, Tong W, Zhang X, Chen L, Yi Z, Pan T, et al. Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells. FEBS Lett. 2006;580:4392–400.PubMedPubMedCentralCrossRefGoogle Scholar
  137. Weiwad M, Edlich F, Erdmann F, Jarczowski F, Kilka S, Dorn M, Pechstein A, Fischer G. A reassessment of the inhibitory capacity of human FKBP38 on calcineurin. FEBS Lett. 2005;579:1591–6.PubMedPubMedCentralCrossRefGoogle Scholar
  138. Woods SW, Charney DS, Delgado PL, Heninger GR. The effect of long-term imipramine treatment on carbon dioxide-induced anxiety in panic disorder patients. J Clin Psychiatry. 1990;51:505–7.PubMedPubMedCentralGoogle Scholar
  139. Xiol J, Cora E, Koglgruber R, Chuma S, Subramanian S, Hosokawa M, et al. A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing. Mol Cell. 2012;47:970–9.PubMedPubMedCentralCrossRefGoogle Scholar
  140. Yakkundi A, Bennett R, Hernandez-Negrete I, Delalande JM, Hanna M, Lyubomska O, et al. FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis. Arterioscler Thromb Vasc Biol. 2015;35:845–54.PubMedPubMedCentralCrossRefGoogle Scholar
  141. Yang WM, Yao YL, Seto E. The FK506-binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1. EMBO J. 2001;20:4814–25.PubMedPubMedCentralCrossRefGoogle Scholar
  142. Yano M, Terada K, Mori M. AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. J Cell Biol. 2003;163:45–56.PubMedPubMedCentralCrossRefGoogle Scholar
  143. Yeh WC, Li TK, Bierer BE, McKnight SL. Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. Proc Natl Acad Sci U S A. 1995;92:11081–5.PubMedPubMedCentralCrossRefGoogle Scholar
  144. Yoon MS, Sun Y, Arauz E, Jiang Y, Chen J. Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect. J Biol Chem. 2011;286:29568–74.PubMedPubMedCentralCrossRefGoogle Scholar
  145. Zhou Q, Lavorgna A, Bowman M, Hiscott J, Harhaj EW. Aryl hydrocarbon receptor interacting protein targets IRF7 to suppress antiviral signaling and the induction of Type I interferon. J Biol Chem. 2015;290:14729–39.PubMedPubMedCentralCrossRefGoogle Scholar
  146. Zimmermann R. The role of molecular chaperones in protein transport into the mammalian endoplasmic reticulum. Biol Chem. 1998;379:275–82.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Paolo D’Arrigo
    • 1
  • Martina Tufano
    • 1
  • Anna Rea
    • 1
  • Simona Romano
    • 1
  • Maria Fiammetta Romano
    • 1
  1. 1.Department of Molecular Medicine and Medical BiotechnologyUniversity of Naples “Federico II”NaplesItaly